Abstract
Recognition of a bacterial attack is the first and the most important step in clearing the bacteria from the body of the host. Towards this, the host innate immune system employs pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), nucleotide-binding leucine-rich repeat-containing receptors (NLRs) and scavenger receptors (SRs) present mostly in innate immune cells. These receptors sense the presence of bacteria and help in spreading the signal to the host, which results in recruitment of other immune cells leading to the elimination of the bacteria from the system. Since their discovery, a lot has been established about these receptors. Their role has been elucidated not only in pathogen recognition but also in eradication of the dead cells from the system. This review is focussed mainly on their role in the bacterial recognition and how these receptors play a role in eliciting an immune response against bacteria in the host.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511 doi:10.1038/nri1391nri1391[pii]
Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675–680 doi:10.1038/9060990609[pii]
Allen IC et al (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207:1045–1056 doi:jem.20100050 [pii]10.1084/jem.20100050
Armant MA, Fenton MJ (2002) Toll-like receptors: a family of pattern-recognition receptors in mammals. Genome Biol 3:REVIEWS3011
Arredouani MS (2014) Is the scavenger receptor MARCO a new immune checkpoint? Oncoimmunology 3:e955709. https://doi.org/10.4161/21624011.2014.955709
Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN (2007) TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13:543–551 doi:nm1590 [pii]10.1038/nm1590
Baranova IN et al (2008) Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol 181:7147–7156
Bauernfeind FG et al (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787–791 doi:jimmunol.0901363 [pii]10.4049/jimmunol.0901363
Ben J, Zhu X, Zhang H, Chen Q (2015) Class A1 scavenger receptors in cardiovascular diseases. Br J Pharmacol 172:5523–5530 doi:10.1111/bph.13105
Bertheloot D et al (2016) RAGE enhances TLR responses through binding and internalization of RNA. J Immunol 197:4118–4126 doi:10.4049/jimmunol.1502169
Bertrand MJ, Doiron K, Labbe K, Korneluk RG, Barker PA, Saleh M (2009) Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30:789–801 doi:S1074-7613(09)00203-9 [pii]10.1016/j.immuni.2009.04.011
Beutler BA (2009) TLRs and innate immunity. Blood 113:1399–1407 doi:blood-2008-07-019307 [pii]10.1182/blood-2008-07-019307
Bierhaus A et al (2001) Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50:2792–2808
Bowdish DM et al (2009) MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5:e1000474. https://doi.org/10.1371/journal.ppat.1000474
Broz P, von Moltke J, Jones JW, Vance RE, Monack DM (2010) Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 8:471–483 doi:S1931-3128(10)00380-X [pii]10.1016/j.chom.2010.11.007
Canton J, Neculai D, Grinstein S (2013) Scavenger receptors in homeostasis and immunity. Nat Rev Immunol 13:621–634. https://doi.org/10.1038/nri3515
Cao D, Luo J, Chen D, Xu H, Shi H, Jing X, Zang W (2016) CD36 regulates lipopolysaccharide-induced signaling pathways and mediates the internalization of Escherichia coli in cooperation with TLR4 in goat mammary gland epithelial cells. Sci Rep 6:23132. https://doi.org/10.1038/srep23132
Cervantes JL, Weinerman B, Basole C, Salazar JC (2012) TLR8: the forgotten relative revindicated. Cell Mol Immunol 9:434–438 doi:cmi201238 [pii]10.1038/cmi.2012.38
Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7:758–765 doi:ncb0805-758 [pii]10.1038/ncb0805-758
Chuong C, Katz J, Pauley KM, Bulosan M, Cha S (2009) RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line. J Cell Physiol 221:430–434. https://doi.org/10.1002/jcp.21873
Coller SP, Paulnock DM (2001) Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J Leukocyte Biol 70:142–148
Delneste Y et al (2002) Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353–362
Demaria O et al (2010) TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 120:3651–3662 doi:42081 [pii]10.1172/JCI42081
Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–677 doi:1156995 [pii]10.1126/science.1156995
Doyle SE et al (2004) Toll-like receptors induce a phagocytic gene program through p38. J Exp Med 199:81–90. https://doi.org/10.1084/jem.20031237
Duewell P et al (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464:1357–1361 doi:nature08938 [pii]10.1038/nature08938
Duncan JA et al (2009) Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol 182:6460–6469 doi:182/10/6460 [pii]10.4049/jimmunol.0802696
Dupaul-Chicoine J et al (2010) Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32:367–378 doi:S1074-7613(10)00082-8 [pii]10.1016/j.immuni.2010.02.012
Etzerodt A, Moestrup SK (2013) CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal 18:2352–2363. https://doi.org/10.1089/ars.2012.4834
Eugenin J, Vecchiola A, Murgas P, Arroyo P, Cornejo F, von Bernhardi R (2016) Expression pattern of scavenger receptors and amyloid-beta phagocytosis of astrocytes and microglia in culture are modified by acidosis: implications for Alzheimer’s disease. J Alzheimer’s Dis: JAD 53:857–873. https://doi.org/10.3233/JAD-160083
Fabriek BO et al (2009) The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 113:887–892. https://doi.org/10.1182/blood-2008-07-167064
Faustin B et al (2007) Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 25:713–724 doi:S1097-2765(07)00078-0 [pii]10.1016/j.molcel.2007.01.032
Fernandes-Alnemri T et al (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11:385–393 doi:ni.1859 [pii]10.1038/ni.1859
Ferwerda G et al (2005) NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 1:279–285. https://doi.org/10.1371/journal.ppat.0010034
Finger JN et al (2012) Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity. J Biol Chem 287:25030–25037 doi:M112.378323 [pii]10.1074/jbc.M112.378323
Fitzgerald ML, Moore KJ, Freeman MW, Reed GL (2000) Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J Immunol 164:2692–2700
Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G (2009) The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 10:241–247 doi:ni.1703 [pii]10.1038/ni.1703
Frew BC, Joag VR, Mogridge J (2012) Proteolytic processing of Nlrp1b is required for inflammasome activity. PLoS Pathog 8:e1002659 doi:10.1371/journal.ppat.1002659PPATHOGENS-D-11-02650[pii]
Fukazawa A, Alonso C, Kurachi K, Gupta S, Lesser CF, McCormick BA, Reinecker HC (2008) GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog 4:e1000228. https://doi.org/10.1371/journal.ppat.1000228
Furrie E, Macfarlane S, Thomson G, Macfarlane GT (2005) Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115:565–574 doi:IMM2200 [pii]10.1111/j.1365-2567.2005.02200.x
Girardin SE et al (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584–1587. https://doi.org/10.1126/science.1084677300/5625/1584
Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597–605. https://doi.org/10.1161/CIRCULATIONAHA.106.621854
Gomariz RP, Gutierrez-Canas I, Arranz A, Carrion M, Juarranz Y, Leceta J, Martinez C (2010) Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics. Curr Pharm Des 16:1063–1080 doi:BSP/CPD/E-Pub/00010[pii]
Gorden KB et al (2005) Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 174:1259–1268 doi:174/3/1259[pii]
Granucci F, Petralia F, Urbano M, Citterio S, Di Tota F, Santambrogio L, Ricciardi-Castagnoli P (2003) The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia. Blood 102:2940–2947. https://doi.org/10.1182/blood-2002-12-3651
Grimes CL, Ariyananda Lde Z, Melnyk JE, O’Shea EK (2012) The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment. J Am Chem Soc 134:13535–13537. https://doi.org/10.1021/ja303883c
Gursel M, Gursel I, Mostowski HS, Klinman DM (2006) CXCL16 influences the nature and specificity of CpG-induced immune activation. J Immunol 177:1575–1580
Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI (2002) Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3:354–359 doi:10.1038/ni777ni777[pii]
Hasegawa M et al (2006) Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J Biol Chem 281:29054–29063 doi:M602638200 [pii]10.1074/jbc.M602638200
Hendrickx DA, Koning N, Schuurman KG, van Strien ME, van Eden CG, Hamann J, Huitinga I (2013) Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis. J Neuropathol Exp Neurol 72:106–118. https://doi.org/10.1097/NEN.0b013e31827fd9e8
Hennessy EJ, Parker AE, O’Neill LA (2010) Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9:293–307. https://doi.org/10.1038/nrd3203
Hoebe K et al (2005) CD36 is a sensor of diacylglycerides. Nature 433:523–527. https://doi.org/10.1038/nature03253
Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor kappaB signaling. Immunol Rev 210:171–186 doi:IMR375 [pii]10.1111/j.0105-2896.2006.00375.x
Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A (2002) Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med 195:559–570
Hsu HY, Hajjar DP, Khan KM, Falcone DJ (1998) Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J Biol Chem 273:1240–1246
Hsu HY, Chiu SL, Wen MH, Chen KY, Hua KF (2001) Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem 276:28719–28730. https://doi.org/10.1074/jbc.M011117200
Hsu YM et al (2007) The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 8:198–205 doi:ni1426 [pii]10.1038/ni1426
Hsu LC et al (2008) A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A 105:7803–7808 doi:0802726105 [pii]10.1073/pnas.0802726105
Huysamen C, Brown GD (2009) The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol Lett 290:121–128. https://doi.org/10.1111/j.1574-6968.2008.01418.x
Ibrahim ZA, Armour CL, Phipps S, Sukkar MB (2013) RAGE and TLRs: relatives, friends or neighbours? Mol Immunol 56:739–744. https://doi.org/10.1016/j.molimm.2013.07.008
Imler JL, Hoffmann JA (2001) Toll receptors in innate immunity. Trends Cell Biol 11:304–311
Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987–995 doi:10.1038/ni1112ni1112[pii]
Jack CS et al (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175:4320–4330 doi:175/7/4320[pii]
Jeannin P et al (2005) Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22:551–560. https://doi.org/10.1016/j.immuni.2005.03.008
Jing J et al (2013) Role of macrophage receptor with collagenous structure in innate immune tolerance. J Immunol 190:6360–6367. https://doi.org/10.4049/jimmunol.1202942
Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13:816–825 doi:4401850[pii]10.1038/sj.cdd.4401850
Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol 11:373–384. https://doi.org/10.1038/ni.1863
Kawai T et al (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167:5887–5894
Keestra AM et al (2013) Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 496:233–237 doi:nature12025 [pii]10.1038/nature12025
Kierdorf K, Fritz G (2013) RAGE regulation and signaling in inflammation and beyond. J Leukocyte Biol 94:55–68. https://doi.org/10.1189/jlb.1012519
Kim WS, Ordija CM, Freeman MW (2003) Activation of signaling pathways by putative scavenger receptor class A (SR-A) ligands requires CD14 but not SR-A. Biochem Biophys Res Commun 310:542–549
Kim S, Watarai M, Suzuki H, Makino S, Kodama T, Shirahata T (2004) Lipid raft microdomains mediate class A scavenger receptor-dependent infection of Brucella abortus. Microbial Pathog 37:11–19. https://doi.org/10.1016/j.micpath.2004.04.002
Kimbrell DA, Beutler B (2001) The evolution and genetics of innate immunity. Nat Rev Genet 2:256–267. https://doi.org/10.1038/3506600635066006 [pii]
Kirii H et al (2003) Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23:656–660 doi:10.1161/01.ATV.0000064374.15232.C301.ATV.0000064374.15232.C3[pii]
Kneidl J, Loffler B, Erat MC, Kalinka J, Peters G, Roth J, Barczyk K (2012) Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Cell Microbiol 14:914–936. https://doi.org/10.1111/j.1462-5822.2012.01766.x
Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA (2002a) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191–202
Kobayashi K et al (2002b) RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416:194–199 doi:10.1038/416194a416194a[pii]
Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731–734 doi:307/5710/731 [pii]10.1126/science.1104911
Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, Chazin WJ, Fritz G (2010) Structural basis for ligand recognition and activation of RAGE. Structure 18:1342–1352. https://doi.org/10.1016/j.str.2010.05.017
Krieg A et al (2009) XIAP mediates NOD signaling via interaction with RIP2. Proc Natl Acad Sci U S A 106:14524–14529 doi:0907131106 [pii]10.1073/pnas.0907131106
Kzhyshkowska J, Neyen C, Gordon S (2012) Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 217:492–502. https://doi.org/10.1016/j.imbio.2012.02.015
Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J, Caron M (2006) Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162–2173. https://doi.org/10.1007/s00125-006-0335-z
Lamkanfi M et al (2009) Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187:61–70 doi:jcb.200903124 [pii]10.1083/jcb.200903124
Laroui H et al (2011) L-Ala-gamma-D-Glu-meso-diaminopimelic acid (DAP) interacts directly with leucine-rich region domain of nucleotide-binding oligomerization domain 1, increasing phosphorylation activity of receptor-interacting serine/threonine-protein kinase 2 and its interaction with nucleotide-binding oligomerization domain 1. J Biol Chem 286:31003–31013 doi:M111.257501 [pii]10.1074/jbc.M111.257501
Lee JG, Lim EJ, Park DW, Lee SH, Kim JR, Baek SH (2008) A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation. Cell Signal 20:2266–2275. https://doi.org/10.1016/j.cellsig.2008.08.022
Lee GS et al (2013) The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492:123–127 doi:nature11588 [pii]10.1038/nature11588
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973–983
Lightfield KL et al (2008) Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat Immunol 9:1171–1178 doi:ni.1646 [pii]10.1038/ni.1646
Lightfield KL et al (2011) Differential requirements for NAIP5 in activation of the NLRC4 inflammasome. Infect Immun 79:1606–1614 doi:IAI.01187-10 [pii]10.1128/IAI.01187-10
Lubrano V, Balzan S (2014) LOX-1 and ROS, inseparable factors in the process of endothelial damage. Free radical Res 48:841–848. https://doi.org/10.3109/10715762.2014.929122
Mandrup-Poulsen T, Pickersgill L, Donath MY (2010) Blockade of interleukin 1 in type 1 diabetes mellitus. Nat Rev Endocrinol 6:158–166 doi:nrendo.2009.271 [pii]10.1038/nrendo.2009.271
Mariathasan S et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213–218 doi:10.1038/nature02664nature02664[pii]
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426 doi:S1097-2765(02)00599-3[pii]
Matloubian M, David A, Engel S, Ryan JE, Cyster JG (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1:298–304. https://doi.org/10.1038/79738
Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145. https://doi.org/10.1038/35100529
Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394–397. https://doi.org/10.1038/41131
Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G (2006) Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69:36–45. https://doi.org/10.1016/j.cardiores.2005.09.006
Miao EA et al (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A 107:3076–3080 doi:0913087107 [pii]10.1073/pnas.0913087107
Moore KJ, Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26:1702–1711. https://doi.org/10.1161/01.ATV.0000229218.97976.43
Mukhopadhyay S, Peiser L, Gordon S (2004) Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype. J Leukocyte Biol 76:577–584. https://doi.org/10.1189/jlb.0104014
Mukhopadhyay S et al (2006) MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitidis. Eur J Immunol 36:940–949. https://doi.org/10.1002/eji.200535389
Mukhopadhyay S, Varin A, Chen Y, Liu B, Tryggvason K, Gordon S (2011) SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 117:1319–1328. https://doi.org/10.1182/blood-2010-03-276733
Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, Horng T (2012) Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109:11282–11287 doi:1117765109 [pii]10.1073/pnas.1117765109
Murshid A, Borges TJ, Calderwood SK (2015a) Emerging roles for scavenger receptor SREC-I in immunity. Cytokine 75:256–260. https://doi.org/10.1016/j.cyto.2015.02.009
Murshid A, Gong J, Prince T, Borges TJ, Calderwood SK (2015b) Scavenger receptor SREC-I mediated entry of TLR4 into lipid microdomains and triggered inflammatory cytokine release in RAW 264.7 cells upon LPS activation. PloS one 10:e0122529. https://doi.org/10.1371/journal.pone.0122529
Murshid A, Borges TJ, Lang BJ, Calderwood SK (2016) The scavenger receptor SREC-I cooperates with toll-like receptors to trigger inflammatory innate immune responses. Front Immunol 7:226. https://doi.org/10.3389/fimmu.2016.00226
Nakamura T, Suzuki H, Wada Y, Kodama T, Doi T (2006) Fucoidan induces nitric oxide production via p38 mitogen-activated protein kinase and NF-kappaB-dependent signaling pathways through macrophage scavenger receptors. Biochem Biophysl Res Commun 343:286–294. https://doi.org/10.1016/j.bbrc.2006.02.146
Ohki I et al (2005) Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL. Structure 13:905–917. https://doi.org/10.1016/j.str.2005.03.016
O’Neill LA, Bryant CE, Doyle SL (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 61:177–197 doi:pr.109.001073 [pii]10.1124/pr.109.001073
O’Neill LA, Golenbock D, Bowie AG (2013) The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol 13:453–460 doi:nri3446 [pii]10.1038/nri3446
Opitz B et al (2004) Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279:36426–36432 doi:10.1074/jbc.M403861200M403861200[pii]
Opitz B et al (2005) Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 96:319–326 doi:01.RES.0000155721.83594.2c [pii]10.1161/01.RES.0000155721.83594.2c
Palma AS et al (2006) Ligands for the beta-glucan receptor, Dectin-1, assigned using “designer” microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem 281:5771–5779. https://doi.org/10.1074/jbc.M511461200
Park H, Adsit FG, Boyington JC (2005) The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1. J Biol Chem 280:13593–13599. https://doi.org/10.1074/jbc.M500768200
Park JH et al (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178:2380–2386 doi:178/4/2380[pii]
Pelegrin P, Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071–5082 doi:7601378 [pii]10.1038/sj.emboj.7601378
Pepino MY, Kuda O, Samovski D, Abumrad NA (2014) Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism. Ann Rev Nutr 34:281–303. https://doi.org/10.1146/annurev-nutr-071812-161220
Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823
Pikkarainen T, Brannstrom A, Tryggvason K (1999) Expression of macrophage MARCO receptor induces formation of dendritic plasma membrane processes. J Biol Chem 274:10975–10982
Pluddemann A et al (2009) SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors. J Innate Immun 1:153–163. https://doi.org/10.1159/000155227
Poltorak A et al (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088
Popescu BF, Lucchinetti CF (2012) Pathology of demyelinating diseases. Ann Rev Pathol 7:185–217. https://doi.org/10.1146/annurev-pathol-011811-132443
Prabhudas M et al (2014) Standardizing scavenger receptor nomenclature. J Immunol 192:1997–2006. https://doi.org/10.4049/jimmunol.1490003
Qu Y et al (2011) Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. J Immunol 186:6553–6561 doi:jimmunol.1100478 [pii]10.4049/jimmunol.1100478
Qureshi S, Medzhitov R (2003) Toll-like receptors and their role in experimental models of microbial infection. Genes Immun 4:87–94 doi:10.1038/sj.gene.63639376363937[pii]
Resnick D, Chatterton JE, Schwartz K, Slayter H, Krieger M (1996) Structures of class A macrophage scavenger receptors. Electron microscopic study of flexible, multidomain, fibrous proteins and determination of the disulfide bond pattern of the scavenger receptor cysteine-rich domain. J Biol Chem 271:26924–26930
Sakaguchi M et al (2011) TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PloS One 6:e23132. https://doi.org/10.1371/journal.pone.0023132
Schaefer L et al (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115:2223–2233. https://doi.org/10.1172/JCI23755
Schorey JS, Lawrence C (2008) The pattern recognition receptor Dectin-1: from fungi to mycobacteria. Curr Drug Targets 9:123–129
Schroder K, Tschopp J (2010) The inflammasomes. Cell 140:821–832 doi:S0092-8674(10)00075-9 [pii]10.1016/j.cell.2010.01.040
Shimaoka T, Kume N, Minami M, Hayashida K, Sawamura T, Kita T, Yonehara S (2001) LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. J Immunol 166:5108–5114
Shimaoka T et al (2003) Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J Immunol 171:1647–1651
Silverstein RL, Febbraio M (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2:re3. https://doi.org/10.1126/scisignal.272re3
Slack JL, Schooley K, Bonnert TP, Mitcham JL, Qwarnstrom EE, Sims JE, Dower SK (2000) Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J Biol Chem 275:4670–4678
Slauenwhite D, Johnston B (2015) Regulation of NKT cell localization in homeostasis and infection. Front Immunol 6:255. https://doi.org/10.3389/fimmu.2015.00255
Stewart CR et al (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11:155–161. https://doi.org/10.1038/ni.1836
Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C, Ogawa H (2002) Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109:1351–1359. https://doi.org/10.1172/JCI14704
Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1–14 doi:17/1/1 [pii]10.1093/intimm/dxh186
Tamura Y et al (2004) Scavenger receptor expressed by endothelial cells I (SREC-I) mediates the uptake of acetylated low density lipoproteins by macrophages stimulated with lipopolysaccharide. J Biol Chem 279:30938–30944. https://doi.org/10.1074/jbc.M313088200
Thakkar S, Wang X, Khaidakov M, Dai Y, Gokulan K, Mehta JL, Varughese KI (2015) Structure-based design targeted at LOX-1, a receptor for oxidized low-density lipoprotein. Sci Rep 5:16740. https://doi.org/10.1038/srep16740
Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, Triantafilou K (2006) Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281:31002–31011. https://doi.org/10.1074/jbc.M602794200
Viala J et al (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5:1166–1174 doi:ni1131 [pii]10.1038/ni1131
West AP et al (2011) TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472:476–480 doi:nature09973 [pii]10.1038/nature09973
Wilkinson K, El Khoury J (2012) Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer’s disease. Int J Alzheimer’s Dis 2012:489456. https://doi.org/10.1155/2012/489456
Wittel UA et al (2015) The chemokine ligand CXCL16 is an indicator of bacterial infection in necrotizing pancreatitis. Pancreatol: Off J Int Assoc Pancreatol 15:124–130. https://doi.org/10.1016/j.pan.2015.01.004
Wu Z, Sawamura T, Kurdowska AK, Ji HL, Idell S, Fu J (2011) LOX-1 deletion improves neutrophil responses, enhances bacterial clearance, and reduces lung injury in a murine polymicrobial sepsis model. Infect Immun 79:2865–2870. https://doi.org/10.1128/IAI.01317-10
Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L (2000) Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408:111–115. https://doi.org/10.1038/35040600
Xu H, Xu W, Chu Y, Gong Y, Jiang Z, Xiong S (2005) Involvement of up-regulated CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in endotoxin-induced lethal liver injury via regulation of T-cell recruitment and adhesion. Infect Immun 73:4007–4016. https://doi.org/10.1128/IAI.73.7.4007-4016.2005
Yamamoto Y et al (2011) Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol 186:3248–3257. https://doi.org/10.4049/jimmunol.1002253
Yu M et al (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174–179 doi:10.1097/01.shk.0000225404.51320.8200024382-200608000-00011[pii]
Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD (2010) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32:379–391 doi:S1074-7613(10)00086-5 [pii]10.1016/j.immuni.2010.03.003
Zani IA, Stephen SL, Mughal NA, Russell D, Homer-Vanniasinkam S, Wheatcroft SB, Ponnambalam S (2015) Scavenger receptor structure and function in health and disease. Cells 4:178–201. https://doi.org/10.3390/cells4020178
Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168:554–561
Zhao W, Ma G, Chen X (2014) Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-kappaB pathway. Vasc Pharmacol 63:162–172. https://doi.org/10.1016/j.vph.2014.06.008
Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140 doi:ni.1831 [pii]10.1038/ni.1831
Zhu XD et al (2011) Caveolae-dependent endocytosis is required for class A macrophage scavenger receptor-mediated apoptosis in macrophages. J Biol chem 286:8231–8239. https://doi.org/10.1074/jbc.M110.145888
Zilbauer M et al (2007) A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni. Cell Microbiol 9:2404–2416 doi:CMI969 [pii]10.1111/j.1462-5822.2007.00969.x
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gulati, A., Kaur, D., Krishna Prasad, G.V.R., Mukhopadhaya, A. (2018). PRR Function of Innate Immune Receptors in Recognition of Bacteria or Bacterial Ligands. In: Chattopadhyay, K., Basu, S. (eds) Biochemical and Biophysical Roles of Cell Surface Molecules. Advances in Experimental Medicine and Biology, vol 1112. Springer, Singapore. https://doi.org/10.1007/978-981-13-3065-0_18
Download citation
DOI: https://doi.org/10.1007/978-981-13-3065-0_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3064-3
Online ISBN: 978-981-13-3065-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)